A probability model for evaluating the bias and precision of influenza vaccine effectiveness estimates from case-control studies

Epidemiology and Infection

Volumn 143, Issue 7, 2015, Pages 1417-1426

  Haber, M ^a   An, Q ^a   Foppa, I M ^b   Shay, D K ^b   Ferdinands, J M ^b   Orenstein, W A ^c  

^a EMORY UNIVERSITY   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Influenza vaccines; mathematical modelling; statistics

Indexed keywords

INFLUENZA VACCINE;

ACCURACY; ARTICLE; CALCULATION; CASE CONTROL STUDY; DRUG EFFICACY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS; MATHEMATICAL ANALYSIS; OBSERVATIONAL STUDY; PROBABILITY; RESPIRATORY TRACT INFECTION; SENSITIVITY AND SPECIFICITY; HUMAN; IMMUNOLOGY; INFLUENZA A VIRUS; INFLUENZA, HUMAN; METHODOLOGY; STANDARDS; STATISTICAL BIAS; THEORETICAL MODEL; VACCINATION; VIROLOGY;

BIAS (EPIDEMIOLOGY); CASE-CONTROL STUDIES; HUMANS; INFLUENZA A VIRUS; INFLUENZA VACCINES; INFLUENZA, HUMAN; MODELS, THEORETICAL; PROBABILITY; RESEARCH DESIGN; VACCINATION;

EID: 84926332160     PISSN: 09502688     EISSN: 14694409     Source Type: Journal    
DOI: 10.1017/S0950268814002179     Document Type: Article

References (11)

1. Skowronski DM, et al. Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel network: Results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 2007; 25: 2842-2851.
2. Orenstein EW, et al. Methodological issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. International Journal of Epidemiology 2007; 36: 623-631.
3. De Serres G, et al. The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomized placebocontrolled clinical trials. Eurosurveillance 2013; 18: 20585.
4. Cowling BJ, et al. Increased risk of non-influenza respiratory virus infection associated with receipt of inactivated influenza vaccine. Clinical Infectious Diseases 2012; 54: 1778-1783.
5. Haber M, Longini IM, Halloran ME. Measures of the effects of vaccination in a randomly mixing population. International Journal of Epidemiology 1991; 20: 300-310.
6. Agresti A. Categorical Data Analysis, 3rd edn. Wiley-Interscience, 2013.
7. Osterholm MT, et al. Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infectious Diseases 2012; 12: 36-44.
8. Centers for Disease Control and Prevention. Surveillance of influenza vaccination coverage-United States, 2007-08 through 2011-12 influenza seasons. Morbidity and Mortality Weekly Reports 2013; 62: 1-28.
9. Ferdinands JM, Shay DK. Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination. Clinical Infectious Diseases 2012; 54: 25-32.
10. Foppa IM, et al. The case test-negative design for studies of the effectiveness of the influenza vaccine. Vaccine 2013; 31: 3104-3109.
11. Jackson ML, Nelson JC. The test-negative design for estimating influenza vaccine effectiveness. Vaccine 2013; 31: 2165-2168.